Glaxosmithkline Uk Limited competitive analysis

Explore patent oppositions filed by Glaxosmithkline Uk Limited against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Medicaments For Increasing Endogenous Erythropoietine (Epo)FIBROGEN, INC.Feb 19, 2020
Use Of Hif Alpha Stabilizers For Enhancing ErythropoiesisFIBROGEN, INC.Jun 26, 2019

Latest PTAB cases involving Glaxosmithkline Uk Limited

Discover the latest PTAB cases involving Glaxosmithkline Uk Limited, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Glaxosmithkline Uk Limited with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GLAXOSMITHKLINE UK LIMITED2 - - -
FIBROGEN, INC.117 - 6